Article
MRI/MRSI is best suited for patients with newly diagnosed prostate cancer who are at high risk of extracapsular extent and who are considering various forms of local therapy.
SBRT may offer a safe alternative to CFRT after prostatectomy
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Real-time IRP monitoring may redefine safety and scope of flexible ureteroscopy
Pearls & Perspectives: Understanding and addressing priapism, with Serge Carrier, MD, and Gregory Broderick, MD
Published data support safety, efficacy of vaginal insert for SUI
Enrollment progresses in study for cisplatin-induced hearing loss in testicular cancer
Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
Telehealth in urologic cancer: Lessons learned from the COVID-19 pandemic